Breaking News Instant updates and real-time market news.

AAPL

Apple

$117.55

-0.08 (-0.07%)

, SSNLF

Samsung

07:14
10/18/16
10/18
07:14
10/18/16
07:14

Apple near-term outlook improved, says UBS

UBS analyst Steven Milunovich believe Apple's (AAPL) Q4 guidance could have upside due to an extra week in the quarter and checks that show iPhone 7 demand is a bit better than the iPhone 6s. The analyst also noted the Samsung (SSNLF) Note 7 problem remains a wild card, but believes it should help Apple's retention rate. Milunovich said the current Apple share price reflects a gradual erosion of its installed base and the amount people are willing to spend with Apple, which he believes is conservative. Milunovich reiterated his Buy rating and $127 price target on Apple shares.

AAPL

Apple

$117.55

-0.08 (-0.07%)

SSNLF

Samsung

  • 23

    Oct

  • 25

    Oct

  • 14

    Nov

AAPL Apple
$117.55

-0.08 (-0.07%)

10/14/16
WELS
10/14/16
NO CHANGE
WELS
Intel results likely to be boosted by positive catalysts, says Wells Fargo
Wells Fargo thinks that Intel's (INTC) September quarter report and December quarter guidance will be boosted by several positive catalysts, including signs of improving PC demand, solid revenue momentum at its Data Center Group, and ramping sales of modems for Apple's (AAPL) iPhone 7. The firm keeps a $40-$50 price target on Intel and continues to identify it as a top pick.
10/17/16
GSCO
10/17/16
NO CHANGE
GSCO
Buy
Goldman suggests Apple 'go big' in content with launch of Prime-like service
Goldman Sachs analysts Simona Jankowski and Drew Borst made the case in a new note to investors that Apple (AAPL) should launch a subscription bundle, in the model of Amazon's (AMZN) "Prime" service, in order to reignite growth and avoid commoditization as smartphone sales plateau. Apple has the power to "turn the razor/blade model upside down," argue the analysts, who note that the iPhone giant can afford to be very aggressive in content, by paying premiums for must-have material or pricing services below competitors. An "Apple Prime" subscription bundle priced at $50 month - which would include the iPhone, Apple Music, Apple TV, Apple original content, and potentially live sports - implies EPS generated by "Prime" customers would be over 10% accretive by 2021, the analysts contend. Goldman keeps a Buy rating on Apple shares.
10/17/16
RBCM
10/17/16
NO CHANGE
RBCM
Most of Note impact on Broadcom could be offset, says RBC Capital
RBC Capital analyst Amit Daryanani says that most of the impact on Broadcom (AVGO) of the Samsung Note 7 recall will be offset if consumers returning the Note buy Apple's (AAPL) iPhone 7 devices. The analyst says that Broadcom has $1-$2 more content per device in the iPhones than in the Note, so he thinks that the recall could actually provide "a tailwind for Broadcom." The analyst keeps a $190 price target and Top Pick rating on the stock.
10/18/16
DBAB
10/18/16
NO CHANGE
Target $108
DBAB
Hold
Apple expectations have moved higher, says Deutsche Bank
Deutsche Bank analyst Sherri Scribner believes investor expectations for Apple have already moved higher and are reflecting a September quarter beat and potential guidance raise. To reflect increased build plans at Asian suppliers and a boost from "short-lived" U.S. carrier promotions, Scribner raised her September quarter iPhone estimate to 46M units and December quarter estimate to 75M. Positive iPhone comments should continue in the next two months, supporting the shares into year-end, Scribner tells investors in a pre-earnings research note. She raised her price target for Apple shares to $108 from $105 but keeps a Hold rating on the name citing slowing longer term smartphone growth.
SSNLF Samsung

08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.
10/11/16
DRXL
10/11/16
NO CHANGE
Target $185
DRXL
Buy
Apple could gain 8M iPhone units from Note 7 troubles, says Drexel Hamilton
Drexel Hamilton analyst Brian White estimates Apple (AAPL) has an opportunity to pick up "at least" 8 million incremental iPhone units in calendar year 2016 due to the Galaxy Note 7 being scrapped, noting that original market expectations were for Samsung (SSNLF) to ship about 10M-14M Galaxy Note 7 units in the second half of this year. The "fiasco" could permanently damage Samsung's smartphone brand, resulting in Apple market share gains, White added. The analyst keeps a Buy rating and $185 price target on Apple shares.
10/12/16
WELS
10/12/16
NO CHANGE
WELS
Market Perform
Wells doesn't see Apple as biggest beneficiary from Samsung issues
Wells Fargo analyst Maynard Um attributes the recent rally in shares of Apple (AAPL), at least in part, to Samsung's (SSNLF) issues with its Note 7 phones. Apple gained an incremental $14B in market capitalization at its intraday peak, which the analyst believes embeds more than 3M of incremental iPhone 7 Plus units. Samsung's production halt will help Apple, but other Android vendors with 5.7 inch phones could see a bigger benefit if Android users prefer to stick with Android, Um tells investors in a research note. He points out that LG, Kyocera, and Microsoft (MFST) have 5.7 inch Android phones at U.S. carriers. Um thinks expectations for Apple into earnings "have risen materially." He keeps a Market Perform rating on the iPhone maker. Apple closed yesterday up 25c to $116.30.
10/12/16
RHCO
10/12/16
NO CHANGE
RHCO
Best Buy, GameStop should be able to sidestep Note 7 impact, says SunTrust
SunTrust analyst David Magee, in two separate notes to investors, said that he believes Samsung's (SSNLF) troubles with the Galaxy Note 7 should not translate to shortfalls for either GameStop's (GME) mobile stores or for Best Buy (BBY), as in both cases most of their customers will simply pick different models. Sony's VR headset and other upcoming products in the category are "ideal for customers to try out in stores," added Magee, who keeps a Buy rating on both GameStop and Best Buy.

TODAY'S FREE FLY STORIES

WMT

Walmart

$100.69

-0.18 (-0.18%)

18:13
01/16/18
01/16
18:13
01/16/18
18:13
Periodicals
Wal-Mart COO to be named international CEO, Reuters says »

Wal-Mart Stores COO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

CME

CME Group

$152.20

-0.53 (-0.35%)

18:05
01/16/18
01/16
18:05
01/16/18
18:05
Hot Stocks
CME reaches daily trading volume record for Henry Hub Nat Gas futures on Jan 12 »

CME Group announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 01

    Feb

CE

Celanese

$109.67

-1.67 (-1.50%)

18:02
01/16/18
01/16
18:02
01/16/18
18:02
Hot Stocks
Celanese announces price increases for engineered materials polymer products »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

SRC

Spirit Realty

$8.07

-0.03 (-0.37%)

17:46
01/16/18
01/16
17:46
01/16/18
17:46
Hot Stocks
Spirit Realty funds $35M into Shopko master lease »

Spirit Realty Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$36.01

-1.83 (-4.84%)

17:45
01/16/18
01/16
17:45
01/16/18
17:45
Conference/Events
Nutanix management to meet with Piper Jaffray »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

, CELG

Celgene

$104.82

-1.18 (-1.11%)

17:41
01/16/18
01/16
17:41
01/16/18
17:41
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Juno Therapeutics…

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

CELG

Celgene

$104.82

-1.18 (-1.11%)

NEWA

Newater Technology

$15.80

2.8 (21.54%)

VRS

Verso

$17.00

0.06 (0.35%)

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

IPSEY

Ipsen

RNST

Renasant

$43.86

0.15 (0.34%)

IBKR

Interactive Brokers

$62.45

-0.65 (-1.03%)

CSX

CSX

$58.13

-1.12 (-1.89%)

ATEN

A10 Networks

$7.31

-0.27 (-3.56%)

HTGM

HTG Molecular

$3.50

-0.14 (-3.85%)

HIVE

Aerohive

$5.70

-0.19 (-3.23%)

OBLN

Obalon Therapeutics

$7.93

0.03 (0.38%)

XON

Intrexon

$13.77

-0.94 (-6.39%)

BOOT

Boot Barn

$19.10

-0.15 (-0.78%)

F

Ford

$13.10

-0.13 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 26

    Feb

  • 01

    Mar

  • 25

    Mar

  • 17

    Jan

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

NRZ

New Residential

$17.63

-0.11 (-0.62%)

17:35
01/16/18
01/16
17:35
01/16/18
17:35
Earnings
Breaking Earnings news story on New Residential »

New Residential sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

17:30
01/16/18
01/16
17:30
01/16/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Exelixis »

Exelixis up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

17:30
01/16/18
01/16
17:30
01/16/18
17:30
Hot Stocks
Breaking Hot Stocks news story on Exelixis 

Exelixis trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

CELG

Celgene

$104.82

-1.18 (-1.11%)

, JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

17:27
01/16/18
01/16
17:27
01/16/18
17:27
Periodicals
Celgene in discussions to acquire Juno Therapeutics, WSJ reports »

Celgene (CELG) is in…

CELG

Celgene

$104.82

-1.18 (-1.11%)

JUNO

Juno Therapeutics

$45.60

-3.15 (-6.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

17:25
01/16/18
01/16
17:25
01/16/18
17:25
Conference/Events
CFA Society of New York to hold a discussion »

The CFA Society of New…

YUMA

Yuma Energy

$1.49

-0.14 (-8.59%)

17:21
01/16/18
01/16
17:21
01/16/18
17:21
Syndicate
Breaking Syndicate news story on Yuma Energy »

Yuma Energy files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$67.85

-0.7 (-1.02%)

17:18
01/16/18
01/16
17:18
01/16/18
17:18
Earnings
Pinnacle Financial reports Q4 adjusted EPS 97c, consensus 94c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRZO

Carrizo Oil & Gas

$23.26

-1.07 (-4.40%)

17:16
01/16/18
01/16
17:16
01/16/18
17:16
Syndicate
Carrizo Oil & Gas 1.2M share Block Trade; price range $23.00-$23.15 »

Citi is acting as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

IAG

IAMGold

$6.11

0.03 (0.49%)

17:13
01/16/18
01/16
17:13
01/16/18
17:13
Hot Stocks
IAMGold sees 2018 gold production between 850K and 900K ozs »

IAMGOLD announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BAESY

BAE Systems

$33.20

0.285 (0.87%)

, GD

General Dynamics

$206.33

-4.26 (-2.02%)

17:10
01/16/18
01/16
17:10
01/16/18
17:10
Hot Stocks
BAE Systems and General Dynamics awarded $158M U.S. Navy contract option »

BAE Systems (BAESY) and…

BAESY

BAE Systems

$33.20

0.285 (0.87%)

GD

General Dynamics

$206.33

-4.26 (-2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

URG

UR-Energy

$0.71

-0.032 (-4.30%)

, UUUU

Energy Fuels

$1.66

-0.15 (-8.29%)

17:10
01/16/18
01/16
17:10
01/16/18
17:10
Hot Stocks
UR-Energy and Energy Fuels submit petition to DOC »

Ur-Energy (URG) and…

URG

UR-Energy

$0.71

-0.032 (-4.30%)

UUUU

Energy Fuels

$1.66

-0.15 (-8.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

UUUU

Energy Fuels

$1.66

-0.15 (-8.29%)

, URG

UR-Energy

$0.71

-0.032 (-4.30%)

17:09
01/16/18
01/16
17:09
01/16/18
17:09
Hot Stocks
Energy Fuels, Ur-Energy file petition with DOC over effects of uranium imports »

Energy Fuels (UUUU) and…

UUUU

Energy Fuels

$1.66

-0.15 (-8.29%)

URG

UR-Energy

$0.71

-0.032 (-4.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

FAST

Fastenal

$55.44

-0.15 (-0.27%)

17:08
01/16/18
01/16
17:08
01/16/18
17:08
Hot Stocks
Fastenal raises quarterly dividend to 37c from 32c »

Fastenal reported its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

EGO

Eldorado Gold

$1.35

0.06 (4.65%)

17:07
01/16/18
01/16
17:07
01/16/18
17:07
Hot Stocks
Eldorado Gold sees FY18 gold production 160,000-190,000 ounces »

Sees FY18 development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGO

Eldorado Gold

$1.35

0.06 (4.65%)

17:06
01/16/18
01/16
17:06
01/16/18
17:06
Hot Stocks
Eldorado Gold reports FY17 gold production 285,919 ounces »

Says FY17 revised gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

, IPSEY

Ipsen

17:06
01/16/18
01/16
17:06
01/16/18
17:06
Hot Stocks
Exelixis and Ipsen disclose Phase 3 results of Cabozantinib »

Exelixis (EXEL) and Ipsen…

EXEL

Exelixis

$29.65

-0.73 (-2.40%)

IPSEY

Ipsen

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

ABX

Barrick Gold

$15.20

0.08 (0.53%)

17:05
01/16/18
01/16
17:05
01/16/18
17:05
Hot Stocks
Barrick Gold reports preliminary FY17 gold production of 5.32M ounces »

Barrick Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 22

    Feb

GRA

W.R. Grace

$72.93

-0.63 (-0.86%)

17:05
01/16/18
01/16
17:05
01/16/18
17:05
Hot Stocks
W.R. Grace signs $200M agreement with two Kazakhstan operators »

W. R. Grace & Co. has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

TAT

TransAtlantic Petroleum

$1.23

-0.02 (-1.60%)

17:05
01/16/18
01/16
17:05
01/16/18
17:05
Hot Stocks
TransAtlantic Petroleum forms committee to explore strategic alternatives »

TransAtlantic Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.